Live Breaking News & Updates on Bioniz Therapeutics

Stay updated with breaking news from Bioniz therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

$40.9 million cash balance at the end of 2023 expected to provide cash runway into 2H 2025

Completed enrollment of Phase 2 clinical study of EQ101 in alopecia areata: topline data expected in Q2. ....

New Zealand , Steve Connelly , Arash Mostaghimi , Harvard Medical School , Equillium Inc , Exchange Commission , Ono Pharmaceutical Co Ltd , Bioniz Therapeutics Inc , Bruce Steel , Investor Day , Annual Peptide Therapeutics Symposium , Upcoming Milestones , Full Year , Asset Purchase Agreement , Bioniz Therapeutics , Multi Cytokine Platform , Multi Cytokine Inhibitors , Biocon Limited , Private Securities Litigation Reform Act , Consolidated Statements ,

Longtime BioMarin CEO hands off baton—Chutes & Ladders

Longtime BioMarin CEO hands off baton—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Ocuphire Pharma , Amit Mehta , Derrell Porter , Kirsty Semple , Erin Lavelle , Cellevolve Bio , Sarah Cole , Todd Dickinson , Adrian Ray , Paul Frohna , Michelle Shuffett , Jennifer Towne , Marguerite Hutchinson , Christian Howell , Lori Kunkel , Daiichi Sankyo Plexxikon , Pat Sharp , Jason Fontenot , Jordi Mata Fink , D Mark Mcclung , Lisa Defrancesco , Jonathan Provoost , Gabrielle Masson , Peter Lebowitz , George Magrath , Kevin Hambly ,

IAMA Therapeutics Announces Addition of Paul Frohna M.D., Ph.D., PharmD, Pierandrea Muglia, M.D. and Elaine Wirrell, M.D., to Scientific Advisory Board

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of children affected by ....

Mayo Clinic In Rochester , United States , New Brunswick , United Kingdom , Comunidad Autonoma De Cataluna , San Francisco , Paul Frohna , Elaine Wirrell , Pierandrea Muglia , Andreap Malizia , Lennox Gastaut Foundation , Mental Health , Status Epilepticus Task , Dalhousie University In Halifax , Georgetown University School Of Medicine , Clinical Development , Advisory Board For The Dravet Syndrome Foundation , Head Of Research , Head Of Neurology Early Clinical Development , Translational Medicine At Receptos Inc , University Of Toronto , Early Clinical Development , University Of British Columbia , Department Of Psychiatry , Centre For Addiction , Profibrix Inc ,

Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates

$71.0 million cash balance at the end of 2022 expected to provide cash runway into 2025

Acquired Bioniz Therapeutics, including two first-in-class clinical-stage assets, EQ101 and EQ102, and. | March 23, 2023 ....

United States , Barbara Troupin , Ono Pharmaceutical Co Ltd , Bank Ltd , Equillium Inc , Exchange Commission , Bruce Steel , Bioniz Therapeutics , Ono Pharmaceutical , Upcoming Milestones , Full Year , Australian Rd Tax Incentive , Cash Used , Adjusted Cash Used , Multi Cytokine Platform , Biocon Limited , Private Securities Litigation Reform Act , Consolidated Statements , Nc Stock Exchange , Press Release , Nd Eq Us29446k1060 ,

Equillium : $71.0 million cash balance at the end of 2022 expected to provide cash runway into 2025 Acquired Bioniz Therapeutics, including two first-in-class clinical-stage assets, EQ101 and EQ102, and proprietary product discovery platform Initiated Phase 2 clinical study of EQ101 in alopecia areata and first-in-human clinical study of EQ102 Entered into strategic partnership and an option and asset purchase agreement with Ono Pharmaceutical for the development and commercialization rights to itolizumab,

$71.0 million cash balance at the end of 2022 expected to provide cash runway into 2025

Acquired Bioniz Therapeutics, including two first-in-class clinical-stage. | March 23, 2023 ....

United States , Barbara Troupin , Michael Moore , Equillium Inc , Bank Ltd , Head Of Corporate Communications , Exchange Commission , Ono Pharmaceutical Co Ltd , Bioniz Therapeutics , Ono Pharmaceutical , Bruce Steel , Upcoming Milestones , Full Year , Australian Rd Tax Incentive , Cash Used , Adjusted Cash Used , Multi Cytokine Platform , Biocon Limited , Private Securities Litigation Reform Act , Investor Relations Officer , Corporate Communications , Consolidated Statements , Nc Stock Exchange , Press Release , Wo Eq Us29446k1060 ,